Aquestive Therapeutics, Inc. (AQST) › Shareholders' EquityAquestive Therapeutics, Inc. (AQST) — Shareholders' EquityAnnual figures by period end, from SEC filings.2016-12-31: -$57.20M2017-12-31: -$26.50M2018-12-31: $10.08M2019-12-31: -$6.12M2020-12-31: -$48.50M2021-12-31: -$82.13M2022-12-31: -$118.55M2023-12-31: -$106.49M2024-12-31: -$60.16M2025-12-31: -$33.66M-$33.66M2016-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31-$33.66M—2026-03-04Balance as of period end2024-12-31-$60.16M—2026-03-04Balance as of period end2023-12-31-$106.49M—2026-03-04Balance as of period end2022-12-31-$118.55M—2025-03-05Balance as of period end2021-12-31-$82.13M—2024-03-05Balance as of period end2020-12-31-$48.50M—2023-03-31Balance as of period end2019-12-31-$6.12M-160.7%2022-03-08Balance as of period end2018-12-31$10.08M—2021-03-09Balance as of period end2017-12-31-$26.50M—2020-03-11Balance as of period end2016-12-31-$57.20M—2019-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)